Skip to main content
Clinical Trials/NL-OMON42473
NL-OMON42473
Completed
Not Applicable

YMFOcare: The impact of providing feedback on patients* symptoms and health-related quality of life and offering a self-management website on the self-management of patients with lymphoma. A randomized controlled population-based registry trial. - LYMFOcare

Integraal Kankercentrum Nederland (IKNL)0 sites500 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Integraal Kankercentrum Nederland (IKNL)
Enrollment
500

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • All patients (men and women) that are newly diagnosed with Hodgkin or non\-Hodgkin lymphoma in one of the participating hospitals and were 18 years or older at time of diagnosis.

Exclusion Criteria

  • Unable to complete a Dutch questionnaire.
  • Patients with severe psychopathology or dementia.

Investigators

Sponsor
Integraal Kankercentrum Nederland (IKNL)

Similar Trials